Reckon Diagnostics Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Reckon Diagnostics Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $788.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Reckon Diagnostics Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $788.7K Trade | TransData Nexus

Reckon Diagnostics Private Limited

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $788.7K Total Trade · DGFT Verified

Reckon Diagnostics Private Limited is an Indian pharmaceutical exporter with a total trade value of $788.7K across 2 products in 1 therapeutic categories. Based on 167 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Diagnostic ($642.6K), Reagent ($146.0K), .

Reckon Diagnostics Private Limited — Export Portfolio & Destination Treemap

Reckon Diagnostics Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Reckon Diagnostics Private Limited? — Company Overview & Market Position

Reckon Diagnostics Private Limited, established on October 29, 1984, is a privately held company headquartered in Vadodara, Gujarat, India. The company specializes in the manufacturing of in vitro diagnostic products, including clinical chemistry reagents, serology kits, rapid diagnostic tests, and diagnostic instruments. With over 30 years of experience, Reckon Diagnostics has developed a strong presence in the diagnostic industry.

The company operates with an authorized capital of ₹2.50 crore and a paid-up capital of ₹2.50 crore. As of April 4, 2024, Reckon Diagnostics employed approximately 200 professionals. The leadership team includes Nital Mahendrakumar Patel, serving as the Managing Director since January 1, 1999, and Payal Nital Patel, the Whole-Time Director since January 15, 2008.

What Does Reckon Diagnostics Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Diagnostic$642.6K 2Reagent

Product Portfolio — Top 2 by Export Value

Reckon Diagnostics Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Diagnostic	Medical Devices & Diagnostics	$642.6K	159	3.5%	8
2	Reagent	Medical Devices & Diagnostics	$146.0K	8	1.1%	6

Reckon Diagnostics Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $788.7K. The top category is Medical Devices & Diagnostics (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Reckon Diagnostics Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Reckon Diagnostics operates a state-of-the-art manufacturing facility in Vadodara, Gujarat, covering an area of 30,000 square feet. This facility is designed to meet stringent Good Manufacturing Practices (GMP) standards, ensuring the production of high-quality diagnostic products. The plant specializes in the production of clinical chemistry reagents, serology kits, rapid diagnostic tests, and diagnostic instruments, catering to both domestic and international markets.

3Key Leadership

The leadership team at Reckon Diagnostics Private Limited comprises:

Nital Mahendrakumar Patel: Managing Director since January 1, 1999.

Payal Nital Patel: Whole-Time Director since January 15, 2008.

These leaders have been instrumental in steering the company towards its current position in the diagnostic industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Reckon Diagnostics Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Reckon Diagnostics Private Limited has made significant strides in regulated markets, particularly in the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained necessary regulatory approvals and certifications, including ISO 13485:2016 and GMP certifications, which are essential for market access in these regions. These certifications demonstrate the company's commitment to maintaining high-quality standards in its manufacturing processes.

2Emerging Markets

Reckon Diagnostics has expanded its presence in emerging markets across Africa, Latin America, and Southeast Asia. The company's adherence to international quality standards, such as ISO 13485:2016 and GMP, has facilitated its entry into these markets. By obtaining WHO prequalification, Reckon Diagnostics has enhanced its credibility and marketability in these regions, enabling access to a broader customer base.

3Geographic Strategy

Reckon Diagnostics has strategically diversified its geographic footprint to mitigate concentration risks. The company's operations span across India and extend to various international markets, including the United States, European Union, United Kingdom, Australia, Japan, Africa, Latin America, and Southeast Asia. This diversification strategy allows Reckon Diagnostics to leverage growth opportunities in multiple regions while reducing dependency on any single market.

Reckon Diagnostics Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Reckon Diagnostics Private Limited has registered its manufacturing facility with the U.S. Food and Drug Administration (FDA), a critical step for exporting diagnostic products to the United States. The company has also filed Abbreviated New Drug Applications (ANDAs) and Drug Master Files (DMFs) with the FDA, facilitating the approval process for its products. Reckon Diagnostics maintains a history of successful FDA inspections, reflecting its commitment to adhering to stringent regulatory standards.

2WHO & EU GMP

Reckon Diagnostics holds WHO prequalification, which is essential for supplying diagnostic products to international organizations and various countries. The company has also obtained EU GMP certificates, ensuring compliance with European manufacturing standards. These certifications underscore Reckon Diagnostics' dedication to producing high-quality diagnostic products that meet global standards.

3CDSCO & Indian Regulatory

In India, Reckon Diagnostics Private Limited has secured manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), authorizing it to produce diagnostic products for the domestic market. The company has obtained approvals from state drug controllers and export No Objection Certificates (NOCs), facilitating its export activities. These regulatory approvals demonstrate Reckon Diagnostics' compliance with Indian pharmaceutical regulations.

Reckon Diagnostics Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the diagnostic products sector, Reckon Diagnostics Private Limited faces competition from both domestic and international companies. Key competitors include multinational corporations and established Indian firms specializing in diagnostic reagents and instruments. Reckon Diagnostics differentiates itself through its extensive experience, adherence to international quality standards, and a comprehensive product portfolio. While specific market share data is not available, the company's strategic focus on quality and customer satisfaction positions it favorably in the competitive landscape.

2Key Differentiators

Reckon Diagnostics' key differentiators include its over 30 years of experience in the diagnostic industry, a comprehensive product portfolio encompassing clinical chemistry reagents, serology kits, rapid diagnostic tests, and diagnostic instruments, and a strong commitment to quality, evidenced by ISO 13485:2016 and GMP certifications. The company's focus on customer satisfaction and continuous product development further enhances its competitive edge.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Reckon Diagnostics Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Reckon Diagnostics Private Limited has demonstrated a consistent track record in manufacturing and exporting diagnostic products. The company's export volume and consistency are supported by its adherence to international quality standards and certifications. Reliability indicators include a clean regulatory record and a strong focus on customer satisfaction. These factors contribute to Reckon Diagnostics' reputation as a dependable supplier in the diagnostic products sector.

2Certifications to Verify

Importers should verify the following certifications when considering Reckon Diagnostics Private Limited as a supplier:

FDA Registration: Confirm the company's registration with the U.S. Food and Drug Administration to ensure compliance with U.S. regulations.

WHO Prequalification: Verify the company's prequalification status with the World Health Organization to ensure product quality and safety.

Frequently Asked Questions — Reckon Diagnostics Private Limited

How many pharmaceutical products does Reckon Diagnostics Private Limited export from India?

Reckon Diagnostics Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Diagnostic ($642.6K), Reagent ($146.0K). Total export value is $788.7K.

What is Reckon Diagnostics Private Limited's total pharmaceutical export value?

Reckon Diagnostics Private Limited's total pharmaceutical export value is $788.7K, based on 167 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Reckon Diagnostics Private Limited cover?

Reckon Diagnostics Private Limited exports across 1 therapeutic categories. The largest are Medical Devices & Diagnostics (100.0%, 2 products).

Get Full Reckon Diagnostics Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.